Impact of Preterm Single Donor Milk in Very Low Birth Weight Infants
NCT ID: NCT02216292
Last Updated: 2014-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2012-06-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants
NCT01534481
Preterm Donor Human Milk Supplementation of Mother's Own Milk in VLBW Infants
NCT05675397
Preterm Infants on Early Solid Foods
NCT01809548
Liquid Preterm Formula Versus Powdered Human Milk Fortifier in VLBW Infants
NCT00760942
Prolonged Minimal Enteral Nutrition Versus Slowly Advancing Enteral Nutrition in Very Low Birth Weight Infants:
NCT02913677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preterm Single Donor Milk Group
The prospective study group = preterm single donor milk group (PSDM-Group) from June 2012 - April 2013
Preterm Single Donor Milk Group
Infants received preterm single donor milk during their first days of life until breastmilk from their own mother was available
Control Group
Retrospective control group receiving no donor milk = control group from March 2011 - May 2012
Control Group
Infants received preterm formula during their first days of life until breastmilk from their own mother was available
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control Group
Infants received preterm formula during their first days of life until breastmilk from their own mother was available
Preterm Single Donor Milk Group
Infants received preterm single donor milk during their first days of life until breastmilk from their own mother was available
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational Age \<32 weeks
* Informed consent
Exclusion Criteria
* systemic metabolic diseases
* short bowl syndrome
* gastrointestinal abnormalities
* when preterm infant was transferred or discharged
1 Minute
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nadja Haiden,MD
MD, Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nadja Haiden, Prof.MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna, Department of Pediatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSDM001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.